Osteoarthritis

P186 - Long-Term Survival Of Knee Joint Distraction As Treatment Of End-Stage Knee Osteoarthritis (ID 9650)

Authors
Corresponding Author
Disclosure
No disclosures for van der Weiden, Custers and Mastbergen. This research was kindly supported by Dutch Arthritis Foundation and ZonMW. Lafeber: Co-founder and shareholder ArthroSave BV.
Topic
Osteoarthritis
Rating
 | 

Previous ePoster
P185 - Hymovis® Increases MRI Cartilage Volume And Type II Collagen Turnover In Osteoarthritic Knee: Data From MOKHA Study. (ID 9504)

Next ePosters
P187 - Hyaluronic Acid Injection In Treating Knee Osteoarthritis: Assessing Risk Of Bias In Systematic Reviews With ROBIS Tool (ID 9709)
P188 - Methylprednisolone Acetate Suppresses Endogenous Bone Morphogenetic Protein Expression By Chondrocytes And Synoviocytes (ID 9719)
P189 - Minimally Invasive Treatment Of Anterior Cruciate Ligament Injury Combined With Varus Osteoarthritis Of The Knee (ID 9753)
P190 - Clinical Observation Of Knee Osteoarthritis With Quadriceps Functional Excercises (ID 9878)
P192 - Cartilage regeneration after distal femoral osteotomy in patients with valgus knee osteoarthritis (ID 9992)
P194 - High Physical Activity Predicts Worsening Knee Joint Space Narrowing Over 48 Months: the Osteoarthritis Initiative (ID 10145)
P195 - Joint preserving surgery and arthroscopic autologous matrix-induced chondrogenesis procedures (ID 10165)
P196 - Osteoblasts Secretome Analysis Provides new Insights in Mechanisms Underlying Osteoarthritis Subchondral Bone Sclerosis (ID 9415)
P197 - The Coll2-1 Peptide of Collagen Type II: A New Actor of Synovitis in Osteoarthritis (ID 9429)
P198 - Different Level Of NF-KappaB Acetylation In The Osteoarthritis (ID 9431)